New treatment strategies based on the pathophysiology of Group 2 pulmonary hypertension

1 September 2025 (08:15 - 08:30)

Organised by:

Slides

Sign in to view the resources

About the speaker

Doctor Taijyu Satoh

Tohoku University Hospital, Sendai (Japan)

3 More presentations in this session

Presentation thumbnail

Chronic thromboembolic pulmonary hypertension: alternative anticoagulation with edoxaban to vitamin K antagonists and emerging early diagnostic modality with dynamic chest radiography

Associate Professor K. Hosokawa (Fukuoka, JP)

Presentation thumbnail

Microvesicle markers of pulmonary hypertension

Doctor A. Garcia-Alvarez (Barcelona, ES)

Presentation thumbnail

Prediction models and scores in pulmonary hypertension

Doctor S. Mouratoglou (Thessaloniki, GR)

Access the full session

Session thumbnail

Pulmonary hypertension: evolving strategies in diagnosis and management

The Event

Event poster

ESC Congress 2025

1 September 2025 08:15 CET

You may be interested in

Congress Session

Pulmonary hypertension: evolving strategies in diagnosis and management

Congress Session

Phenotypes and management strategies in pulmonary hypertension

Congress Session

One year after the ESC/ERS pulmonary hypertension Guidelines - how are they affecting our practice?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources